Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Parasitic Diseases

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 44 articles: HTML format

Single Articles

September 2025
1. CAREY-EWEND K, Marten A, Muller J, Peter EE, et al
   Seasonal variation and interspecies dynamics among Plasmodium falciparum and ovale species in Bagamoyo, Tanzania.
   J Infect Dis. 2025 Sep 30:jiaf498. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. DAOUI O, Monsieurs P, Talimi H, Spath GF, et al
   Direct genome sequencing of Leishmania tropica in tissues of Moroccan patients with cutaneous leishmaniasis reveals micro-focal transmission underlain by (pseudo-)clonal and sexual reproduction modes.
   J Infect Dis. 2025 Sep 17:jiaf485. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. JOOF F, Hu R, Seydel KB, Cohee LM, et al
   Febrile temperature augments ring-stage Plasmodium falciparum adhesion to brain endothelial cells.
   J Infect Dis. 2025 Sep 10:jiaf474. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2025
4. MUKEREBE C, Cordeiro AA, Aristide C, Colombe S, et al
   Schistosome Infection is Associated with High-Risk Human Papillomavirus Persistence, Together with Altered Cervicovaginal Microbiota.
   J Infect Dis. 2025 Aug 22:jiaf447. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. FRIEDMAN-KLABANOFF DJ, Jensen TL, Gelber CE, Pinapati RS, et al
   Vaccine-induced antibodies to a C-terminal Plasmodium falciparum circumsporozoite protein epitope are associated with protection.
   J Infect Dis. 2025 Aug 19:jiaf391. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. SAMANDARI T, Achola M, Hutter JN, Mboya G, et al
   Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected Adults.
   J Infect Dis. 2025 Aug 2:jiaf398. doi: 10.1093.
   PubMed     Abstract available
   
   
   July 2025
7. CHO H, Paun A, Seo Y, Lee SH, et al
   A human monoclonal antibody targeting alpha-Gal ameliorates experimental cutaneous leishmaniasis.
   J Infect Dis. 2025 Jul 1:jiaf350. doi: 10.1093.
   PubMed     Abstract available
   
   
   June 2025
8. DUNCAN NR, O'Connell EM, Guzman JJ, Lacsina JR, et al
   From skin to sequence: pan-species detection and speciation of Leishmania.
   J Infect Dis. 2025 Jun 26:jiaf345. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. SONG Y, Deng B, Long CA, Li Q, et al
   Priming or Boosting P. falciparum Transmission Blocking Responses with Recombinant Vaccines or Gametocyte Extract.
   J Infect Dis. 2025 Jun 12:jiaf318. doi: 10.1093.
   PubMed     Abstract available
   
   
   May 2025
10. COPELAND NK, Otieno L, Otieno JD, Otieno S, et al
    Efficacy of RTS,S/AS01E only seen in baseline parasitemic and not baseline aparasitemic Plasmodium falciparum-exposed, drug-treated Kenyan adults.
    J Infect Dis. 2025 May 29:jiaf274. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2025
11. SETH A, Dutta M, Sarkar R, Prusti P, et al
    DHEA counteracts Leishmania donovani-induced cortisol: GR signalling-mediated immunosuppression and anti-inflammatory bias.
    J Infect Dis. 2025 Apr 28:jiaf223. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. TANG R, Sun T, Xing Z, Fan X, et al
    Glucocorticoid Receptor Inhibits the Progression of Schistosomiasis Hepatic Fibrosis Through Inducing Circadian Clock Gene Per1.
    J Infect Dis. 2025 Apr 4:jiaf104. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2025
13. FANCONY C, Fortes-Gabriel E, Zage F, Alexiou E, et al
    Artemether-Lumefantrine treatment selects Plasmodium falciparum multidrug resistance 1 (pfmdr1) increased copy number among African malaria infections.
    J Infect Dis. 2025 Mar 26:jiaf155. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2025
14. WANG Y, Zhang M
    Application of CL Detect Rapid Test for the diagnosis of Post-kala-azar Dermal Leishmaniasis.
    J Infect Dis. 2025 Feb 15:jiaf076. doi: 10.1093.
    PubMed    
    
    
    
15. SCHALLENBERG E, van Loon W, Mbarushimana D, Igiraneza C, et al
    Prevalence of Plasmodium falciparum drug resistance markers pfcrt K76T and pfaat1 S258L in southern Rwanda, 2010 to 2023.
    J Infect Dis. 2025 Feb 12:jiaf068. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. ZORRILLA VO, Espada LJ, Lozano ME, Potter AM, et al
    Sand Fly Surveillance for Molecular Identification and Characterization of Leishmania and Bartonella Species in Peru.
    J Infect Dis. 2025;231.
    PubMed     Abstract available
    
    
    
17. FIGUEIREDO AB, Morais KLP, Silva IT, Maia LBL, et al
    Circulating Soluble Factors and T-Cell Subsets as Immunological Predictors of Therapy Response in Human Cutaneous Leishmaniasis.
    J Infect Dis. 2025 Feb 4:jiaf042. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2024
18. HAGENAH LM, Yeo T, Schindler KA, Jeon JH, et al
    Plasmodium falciparum African PfCRT Mutant Isoforms Conducive to Piperaquine Resistance are Infrequent and Impart a Major Fitness Cost.
    J Infect Dis. 2024 Dec 11:jiae617. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2024
19. LOPEZ-PEREZ M, Viwami F, Ampomah P, Sustic T, et al
    Fc-Afucosylation of VAR2CSA-Specific Immunoglobulin G and Clinical Immunity to Placental Plasmodium falciparum Malaria.
    J Infect Dis. 2024 Nov 25:jiae529. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2024
20. LAPIDUS S, Goheen MM, Sy M, Deme AB, et al
    Two mosquito salivary antigens demonstrate promise as biomarkers of recent exposure to P. falciparum infected mosquito bites.
    J Infect Dis. 2024 Oct 30:jiae525. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. YOON KW, Chu KB, Eom GD, Mao J, et al
    CpG-adjuvanted virus-like particle vaccine induces protective immunity against Leishmania donovani infection.
    J Infect Dis. 2024 Oct 24:jiae526. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. AZAM M, Das VNR, Ramesh V, Gupta T, et al
    Rapid antigen detection test for diagnosis of post kala-azar dermal leishmaniasis: application of CL Detect rapid test for active case detection in the endemic area.
    J Infect Dis. 2024 Oct 9:jiae497. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2024
23. LAURY JE, Mugittu K, Kajeguka DC, Kamugisha E, et al
    Efficacy and safety of artemether-lumefantrine against uncomplicated falciparum malaria infection in Tanzania, 2022, a single arm clinical trial.
    J Infect Dis. 2024 Aug 26:jiae425. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. CHU WY, Verrest L, Younis BM, Musa AM, et al
    Disease-specific differences in pharmacokinetics of paromomycin and miltefosine between post-kala-azar dermal leishmaniasis and visceral leishmaniasis patients in eastern Africa.
    J Infect Dis. 2024 Aug 21:jiae413. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2024
25. FANG T, Ben Mamoun C
    Babesia duncani, a Model Organism for Investigating Intraerythrocytic Parasitism and Novel Antiparasitic Therapeutic Strategies.
    J Infect Dis. 2024;230:263-270.
    PubMed     Abstract available
    
    
    
26. HENDRICKX R, Melkamu R, Tadesse D, Teferi T, et al
    Spliced-Leader RNA as a Dynamic Marker for Monitoring Viable Leishmania Parasites During and After Treatment.
    J Infect Dis. 2024;230:183-187.
    PubMed     Abstract available
    
    
    
27. ROY S, Roy S, Banerjee M, Madbhagat P, et al
    Antileishmanial Activity of Cathelicidin and its Modulation by Leishmania donovani in a cAMP Response Element Modulator-Dependent Manner in Infection.
    J Infect Dis. 2024;230:172-182.
    PubMed     Abstract available
    
    
    June 2024
28. RUIZ AE, Pond-Tor S, Stuart R, Acosta LP, et al
    Antibodies to Helminth Defense Molecule-1 are associated with inflammation, organomegaly, and decreased nutritional status in schistosomiasis japonica.
    J Infect Dis. 2024 Jun 29:jiae330. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. CONCEI?AO JA, Carneiro PP, Dorea AS, Oliveira WN, et al
    The contrasting phenotypes of neutrophils during asymptomatic versus symptomatic Leishmania braziliensis infection.
    J Infect Dis. 2024 Jun 24:jiae317. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. JOOF F, Hu R, Saidi A, Seydel KB, et al
    Plasma from older children in Malawi inhibits Plasmodium falciparum binding in 3D brain microvessels.
    J Infect Dis. 2024 Jun 14:jiae315. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2024
31. HENDRICKX R, Melkamu R, Tadesse D, Teferi T, et al
    Spliced-Leader RNA as a Dynamic Marker for Monitoring Viable Leishmania Parasites During and After Treatment.
    J Infect Dis. 2024 May 28:jiae219. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. PERSSON KEM, Horton JL, Kurtovic L, McCarthy JS, et al
    Declining antibody affinity over time after human vaccination with a Plasmodium falciparum merozoite vaccine candidate.
    J Infect Dis. 2024 May 9:jiae259. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. SINGH OP, Chaubey R, Kushwaha AK, Fay MP, et al
    Visceral Leishmaniasis-Human Immunodeficiency Virus-Coinfected Patients Are Highly Infectious to Sandflies in an Endemic Area in India.
    J Infect Dis. 2024 May 7:jiae156. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2024
34. POLACK B, Mathieu-Begne E, Vallee I, Rognon A, et al
    Experimental Infections Reveal Acquired Zoonotic Capacity of Human Schistosomiasis Trough Hybridization.
    J Infect Dis. 2024 Apr 26:jiae152. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2024
35. ROY S, Roy S, Banerjee M, Madbhagat P, et al
    Antileishmanial activity of cathelicidin and its modulation by Leishmania donovani in a CREM-dependent manner for establishing infection.
    J Infect Dis. 2024 Mar 27:jiae158. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
36. PRAH DA, Laryea-Akrong E
    Asymptomatic Low-Density Plasmodium falciparum Infections: Parasites Under the Host's Immune Radar?
    J Infect Dis. 2024 Feb 13:jiad581. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. FRIEDMAN-KLABANOFF DJ, Berry AA, Travassos MA, Shriver M, et al
    Recombinant full-length Plasmodium falciparum circumsporozoite protein-based vaccine adjuvanted with GLA-LSQ: Results of Phase 1 testing with malaria challenge.
    J Infect Dis. 2024 Feb 8:jiae062. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
38. SCHWAKE CJ, Krueger RM, Hanada T, Chishti AH, et al
    Plasmodium falciparum glutamic acid-rich protein (PfGARP)-independent polyclonal antibodies inhibit malaria parasite growth in human erythrocytes.
    J Infect Dis. 2024 Jan 31:jiae050. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. SILVA NI, Souza PFL, Silva BF, Fonseca SG, et al
    Host transcriptional meta-signatures reveal diagnostic biomarkers for Plasmodium falciparum malaria.
    J Infect Dis. 2024 Jan 25:jiae041. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. OLEINIKOV AV, Seidu Z, Oleinikov IV, Tetteh M, et al
    Profiling the Plasmodium falciparum Erythrocyte Membrane Protein 1-Specific Immununoglobulin G Response Among Ghanaian Children With Hemoglobin S and C.
    J Infect Dis. 2024;229:203-213.
    PubMed     Abstract available
    
    
    November 2023
41. DAHMER KJ, Palma-Cuero M, Ciuoderis K, Patino C, et al
    Molecular Surveillance Detects High Prevalence of the Neglected Parasite Mansonella ozzardi in the Colombian Amazon.
    J Infect Dis. 2023;228:1441-1451.
    PubMed     Abstract available
    
    
    
42. CAREY M, Arju T, Cotton JA, Alam M, et al
    Genomic Heterogeneity of Cryptosporidium parvum Isolates From Children in Bangladesh: Implications for Parasite Biology and Human Infection.
    J Infect Dis. 2023;228:1292-1298.
    PubMed     Abstract available
    
    
    October 2023
43. JAIROCE C, Macia D, Torres-Yaguana JP, Mayer L, et al
    RTS, S/AS02A malaria vaccine-induced IgG responses equally recognize native-like fucosylated and non-fucosylated Plasmodium falciparum circumsporozoite proteins.
    J Infect Dis. 2023 Oct 27:jiad471. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2023
44. ZENO EE, Obala AA, Pence B, Freedman E, et al
    Risk of malaria following untreated sub-patent Plasmodium falciparum infections: Results over 4 years from a cohort in a high transmission area in Western Kenya.
    J Infect Dis. 2023 Sep 15:jiad398. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parasitic Diseases is free of charge.